September 2026
The global blood cancer diagnostics market size is estimated to hit around USD 22.55 billion by 2035 increasing from USD 12.46 billion in 2026, with a CAGR of 6.83%.
September 2026
The global next-generation cancer diagnostics market size is projected to hit around USD 46.43 billion by 2035 from USD 20.28 billion in 2026, with a CAGR of 9.25%.
September 2026
The global non-invasive cancer diagnostics market size is projected to hit around USD 350.78 billion by 2035 from USD 185.94 billion in 2026, with a CAGR of 7.32%.
September 2026
The breast cancer diagnostics market size is valued at USD 21.78 billion in 2026 and is projected to hit around USD 43.62 billion by 2035 with a CAGR of 8.03%.
September 2026
The global prostate cancer diagnostics market size is expected to hit around USD 18 billion by 2035 from USD 10.34 billion in 2026 , with a CAGR of 6.36%.
September 2026
The global cancer diagnostics market size was exhibited at USD 184.96 billion in 2026 and is predicted to surpass around USD 378.44 billion by 2035 with a CAGR of 8.33%.
September 2026
The CAR-T therapies for blood cancers market generated USD 8.09 billion in 2026, with prominent CAR-T therapies for blood cancers market companies including Novartis AG, Gilead Sciences, Inc. (Kite Pharma), Bristol Myers Squibb Company (Celgene/Juno Therapeutics), Johnson & Johnson (Legend Biotech Corporation).
September 2026
The global blood transfusion diagnostics market size was evaluated at USD 5.58 billion in 2026 and is predicted to hit around USD 8.79 billion by 2034, growing at a CAGR of 5.84%.
June 2026
The global bladder cancer therapeutics diagnostics market size was valued at USD 6.01 billion in 2026 and is expected to hit around USD 10.04 billion by 2035, growing at a CAGR of 5.86%.
June 2026
The colorectal cancer diagnostics market size reached USD 16.9 billion in 2025 and is estimated to hit around USD 38.66 billion by 2035 with a CAGR of 8.63%.
December 2025
The global gastric cancer diagnostics market size is evaluated at USD 1.32 billion in 2025 and is predicted to hit around USD 2.72 billion by 2035, growing at a CAGR of 7.51%.
November 2025
The global lung cancer diagnostics market size is estimated at USD 5.35 billion in 2025 and is predicted to hit around USD 9.45 billion by 2034 with a CAGR of 6.53%.
July 2026
The U.S. oncology molecular diagnostics market size is projected to surge USD 2,740 million by 2035 from USD 880 million in 2025 with a notable CAGR of 12.03%.
July 2025
The global biopsy needle market size is expected to attain around USD 2.82 billion by 2034 from USD 1.39 billion in 2024 with a CAGR of 7.33%.
September 2026
The rapid diagnostics market size was estimated at USD 61.75 billion in 2026 and is projected to surpass around USD 322.71 billion in 2035 with a solid CAGR of 20.23%.
September 2026
The blood clot retrieval devices market size reached USD 2.40 billion in 2026, with leading blood clot retrieval devices market companies including AngioDynamics, Terumo Co., Johnson and Johnson.
September 2026
The global guillain barre syndrome diagnostics market size is estimated to hit around USD 206.70 million by 2035 increasing from USD 158.64 million in 2026, with a CAGR of 2.99%.
September 2026
The global blood testing market size was estimated at USD 121.51 billion in 2026 and is projected to hit around USD 224.14 billion by 2035 with a notable CAGR of 7.06%.
September 2026
The precision diagnostics market size was estimated at USD 109.84 billion in 2026, with precision diagnostics market Companies Abbott Laboratories, Bayer AG, Koninklijke Philips N.V., Lantheus Holdings Inc.
September 2026
The liver cancer drug market was valued at USD 5.19 billion in 2026, with leading companies including Bayer AG, Bristol Myers Squibb.
September 2026
The global PCR-based transplant diagnostics market size is estimated to hit around USD 1,286.31 million by 2035 increasing from USD 703.8 million in 2026, with a CAGR of 6.93%.
September 2026
The global esophageal cancer therapeutics market size was evaluated at USD 3.51 billion in 2026 and is predicted to hit around USD 7.75 billion by 2035, growing at a CAGR of 9.22%.
September 2026
The global advanced vehicle diagnostics and remote services market size was evaluated at USD 8.95 billion in 2026 and is predicted to hit around USD 24.28 billion by 2035, growing at a CAGR of 11.73%.
September 2026
The global blood-based non-invasive screening market size was evaluated at USD 16.88 billion in 2026 and is predicted to hit around USD 48.71 billion by 2035, growing at a CAGR of 12.50%.
September 2026
The lung cancer therapeutics market size totalled USD 38.23 billion in 2026, with major lung cancer therapeutics market players including AstraZeneca, BoehringerIngelheim, Bristol-Myers Squibb Company, Eli Lilly and Company, Hoffmann-La Roche, Merck & Co, Pfizer Inc.
September 2026
The global food diagnostics market size is calculated at USD 20.64 billion in 2026 and is projected to hit around USD 36.75 billion by 2035 with a CAGR of 6.63%.
September 2026
The global exosome-based cancer therapy CDMO market is growing as demand rises for scalable manufacturing and delivery solutions in exosome therapeutics.
September 2026
The preeclampsia diagnostics market size reached USD 1.33 billion in 2026, with leading preeclampsia diagnostics market companies including Thermo Fisher Scientific, F. Hoffmann La Roche Ltd, PerkinElmer Inc.
September 2026
The neoantigen cancer vaccine market was worth USD 551.46 million in 2026, with key neoantigen cancer vaccine market players including Moderna Inc, BioNTech SE.
September 2026
The global blood ketone meter market size was evaluated at USD 558.54 million in 2026 and is predicted to hit around USD 1026.85 million by 2035, growing at a CAGR of 7.00%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com